medical cannabis has returned to the center of South Carolina politics as candidates and lawmakers consider narrowly tailored programs for patients with serious conditions. Statements by the two leading Republican primary contenders, combined with Democratic proposals and renewed federal movement on cannabis scheduling, have pushed the issue toward the governor’s race and renewed debate in the legislature.
Republican contenders signal conditional support
Lieutenant Governor Pamela Evette said her experience caring for a terminally ill family member shaped her view. She told voters she would consider signing legislation that allows medical access while explicitly preventing expansion into recreational markets. Evette said any bill she backs must include medical oversight and restrictions to serve only patients with defined, serious conditions.
Attorney General Alan Wilson offered similar conditional support. He cited the federal government’s recent decision to reclassify cannabis from Schedule I to Schedule III and argued that reclassification could open research channels and support treatment development. “I’ve met so many veterans who suffer from post-traumatic stress disorder,” Wilson said, adding that people with epilepsy, chronic illnesses, and terminal conditions could benefit from regulated access. He reiterated opposition to recreational legalization.
Both Republicans framed their positions around patient access and strict regulation. The GOP second-round primary runoff is set for June 23; the winner will face the Democratic nominee in the general election.
Democratic proposal expands scope
State Representative Jermaine Johnson, already the Democratic nominee, supports statewide medical cannabis legalization and a broader reform package. His campaign platform describes medical cannabis as “safe, legal, and accessible” and calls for regulation that would allow licensed cultivation, processing, and retail for patients. Johnson also favors a statewide referendum on recreational legalization and has pledged to commute sentences for people convicted of nonviolent cannabis offenses.
Ongoing legislative efforts
Senator Tom Davis, a Republican, has repeatedly introduced conservative medical cannabis bills designed to limit use to patients with specified diseases, chronic conditions, or terminal illnesses. His proposals would require a physician’s authorization and supervision, and would have pharmacists dispense cannabis products through licensed pharmacies. Some versions of Davis’s bills have passed the South Carolina Senate but have stalled repeatedly in the House of Representatives.
Davis characterized his bills as narrowly focused on patient care and medical oversight. “This requires a doctor’s authorization for the patient, as well as a doctor’s supervision,” he said. “It requires that pharmacists be the ones to dispense it. It’s a very conservative bill, because that’s what the people of South Carolina want.” Lawmakers opposed to current proposals cite concerns about diversion, enforcement, and regulatory costs.
Federal rescheduling and state implications
The federal reclassification of cannabis to Schedule III has changed the legal context. State officials and advocacy groups are examining how that shift affects research, banking, and prescribing. Proponents say Schedule III status reduces regulatory barriers for clinical trials and could allow physicians and researchers in South Carolina to work under clearer federal rules. Opponents warn that reclassification does not automatically resolve state-level restrictions and that careful state-level regulatory language will be required.
Advocates point to specific practical effects they expect if state-level medical programs move forward: increased participation in federally approved research, access to pharmaceutical-grade cannabis products through pharmacies, and regulated supply chains that include licensed growers and processors. Lawmakers will need to set oversight mechanisms, licensing fees, testing standards, and distribution rules if they enact a program.
Public opinion and political context
A 2024 poll found majority support across party lines for legal medical cannabis in South Carolina, and that broad public backing is shaping legislative attention. Political strategists note that support among voters — including a substantial share of Republican voters according to the poll — has made lawmakers more willing to propose narrowly defined medical programs.
What remains unresolved
Key questions remain: which medical conditions qualify, whether pharmacists or dispensaries will distribute products, how the state will license producers, and how regulators will prevent diversion into illicit markets. The House has blocked multiple Senate-passed bills, so movement in the lower chamber will determine whether a narrowly limited medical program can reach a governor’s desk.
Campaign timing will matter. If the June 23 Republican runoff produces a nominee who commits to patient-only access under strict medical oversight, the next legislative session could see renewed attempts to pass a bill tailored to both political and medical concerns. If the House continues to resist, advocates may push for ballot initiatives or a referendum as an alternative route to change.
Bottom line
South Carolina remains one of the few states without an established medical cannabis program. Recent federal action and high voter support have increased pressure on state leaders to act. Candidates across the political spectrum now describe conditional or expansive plans for medical cannabis, but legislative and procedural hurdles in the House will determine whether those plans become law.
